Stelios Papadopoulos

Stelios Papadopoulos is the founder of Exelixis, Inc. (1994) where the title held is Independent Chairman.
Dr. Papadopoulos was the founder of Anadys Pharmaceuticals, Inc. (1992) where the title held was Chairman.
Dr. Papadopoulos is the founder of Cellzome Ltd. (2000) with no titles listed.
Dr. Papadopoulos is the founder of Fondation Santé (2000) where the title held is Chairman & Treasurer.
Dr. Papadopoulos is the founder of Eucrates Biomedical Acquisition Corp.
(2020) where the title held was Chairman.
Dr. Papadopoulos was also the founder of Epikast, Inc.,Cellzome, Inc...
Dr. Papadopoulos previously served as Director at Diacrin, Inc. (Delaware), Graviton Bioscience Corp., Biogen Idec, Inc. (North Carolina), National Marrow Donor Program, and The BioExec Institute, Inc. Dr. Papadopoulos is Independent Director at Ovid Therapeutics, Inc. starting 2025.
Dr. Papadopoulos is Member-Visitors Board at Duke University Medical Center.
Former positions include Chairman at Biogen, Inc. (2014–2023), Vice Chairman at Cowen & Co. LLC (2000–2006), Chairman at Regulus Therapeutics, Inc. (2013–2025), Chairman-Supervisory Board at Biogen GmbH (2014–2023), Chairman at PaineWebber Development Corp.
(1987–2000), Director at GenVec, Inc. (2006), Director at Neuronyx, Inc., Independent Director at BG Medicine, Inc. (2003–2018), Director at SGX Pharmaceuticals, Inc. (2001–2006), Director at Biogen Idec New Ventures, Inc., Director at Joule Unlimited Technologies, Inc., Vice President-Equity Research Department at Drexel Burnham Lambert, Inc., President at Instrumentation Laboratory Co. (1987–1988), and Investment Banker at PaineWebber, Inc. (1987–2000).
Education includes graduate, MBA, and doctorate degrees from New York University.